| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6147544 | American Journal of Obstetrics and Gynecology | 2007 | 8 Pages |
Abstract
Transdermal nitroglycerin may reduce neonatal morbidity and mortality as a result of decreased risk of birth before 28 weeks.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Graeme N. MD, PhD, Mark C. MD, MSc, Arne MD, MSc, Karel MD, Rory MD, MSc, Canadian Preterm Labour Nitroglycerin Trial Group Canadian Preterm Labour Nitroglycerin Trial Group,